|
mutLBSgeneDB |
| |
| |
| |
| |
| |
| |
|
| Gene summary for SUN2 |
 Gene summary |
| Basic gene Info. | Gene symbol | SUN2 |
| Gene name | Sad1 and UNC84 domain containing 2 | |
| Synonyms | UNC84B | |
| Cytomap | UCSC genome browser: 22q13.1 | |
| Type of gene | protein-coding | |
| RefGenes | NM_001199579.1, NM_001199580.1,NM_015374.2, | |
| Description | SUN domain-containing protein 2Sad1 unc-84 domain protein 2nuclear envelope proteinprotein unc-84 homolog Brab5-interacting proteinrab5IPsad1/unc-84 protein-like 2unc-84 homolog B | |
| Modification date | 20141207 | |
| dbXrefs | MIM : 613569 | |
| HGNC : HGNC | ||
| Ensembl : ENSG00000100242 | ||
| HPRD : 15611 | ||
| Vega : OTTHUMG00000151031 | ||
| Protein | UniProt: Q9UH99 go to UniProt's Cross Reference DB Table | |
| Expression | CleanEX: HS_SUN2 | |
| BioGPS: 25777 | ||
| Pathway | NCI Pathway Interaction Database: SUN2 | |
| KEGG: SUN2 | ||
| REACTOME: SUN2 | ||
| Pathway Commons: SUN2 | ||
| Context | iHOP: SUN2 | |
| ligand binding site mutation search in PubMed: SUN2 | ||
| UCL Cancer Institute: SUN2 | ||
| Assigned class in mutLBSgeneDB | C: This gene just belongs to mutLBSgenes. | |
| Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez |
| GO ID | GO Term | PubMed ID | GO:0090286 | cytoskeletal anchoring at nuclear membrane | 18396275 | GO:0090292 | nuclear matrix anchoring at nuclear membrane | 19933576 |
| Top |
| Ligand binding site mutations for SUN2 |
| Lollipop-style diagram of mutations at LBS in amino-acid sequence. We represented ligand binding site mutations only. (You can see big image via clicking.)  : non-synonymous mutation on LBS, Circle size denotes number of samples. |
 |
| Cancer type specific mutLBS sorted by frequency |
| LBS | AAchange of nsSNV | Cancer type | # samples | Y703 | E702K | COAD | 1 | C601,A603 | W602R | LUAD | 1 | Y707 | R708C | UCEC | 1 |
| cf) Cancer type abbreviation. BLCA: Bladder urothelial carcinoma, BRCA: Breast invasive carcinoma, CESC: Cervical squamous cell carcinoma and endocervical adenocarcinoma, COAD: Colon adenocarcinoma, GBM: Glioblastoma multiforme, LGG: Brain lower grade glioma, HNSC: Head and neck squamous cell carcinoma, KICH: Kidney chromophobe, KIRC: Kidney renal clear cell carcinoma, KIRP: Kidney renal papillary cell carcinoma, LAML: Acute myeloid leukemia, LUAD: Lung adenocarcinoma, LUSC: Lung squamous cell carcinoma, OV: Ovarian serous cystadenocarcinoma, PAAD: Pancreatic adenocarcinoma, PRAD: Prostate adenocarcinoma, SKCM: Skin cutaneous melanoma, STAD: Stomach adenocarcinoma, THCA: Thyroid carcinoma, UCEC: Uterine corpus endometrial carcinoma. |
| Top |
| Protein structure related information for SUN2 |
| Relative protein structure stability change (ΔΔE) using Mupro 1.1 Mupro score denotes assessment of the effect of mutations on thermodynamic stability. (ΔΔE<0: mutation decreases stability, ΔΔE>0: mutation increases stability) |
 : nsSNV at non-LBS : nsSNV at LBS |
 |
| nsSNVs sorted by the relative stability change of protein structure by each mutation Blue: mutations of positive stability change. and red : the most recurrent mutation for this gene. |
| LBS | AAchange of nsSNV | Relative stability change | Y703 | E702K | -1.2286536 | Y707 | R708C | -1.1761747 | C601 | W602R | -0.71000906 | A603 | W602R | -0.71000906 |
| (MuPro1.1: Jianlin Cheng et al., Prediction of Protein Stability Changes for Single-Site Mutations Using Support Vector Machines, PROTEINS: Structure, Function, and Bioinformatics. 2006, 62:1125-1132) |
| Structure image for SUN2 from PDB |
| Top |
| Differential gene expression and gene-gene network for SUN2 |
| Differential gene expression between mutated and non-mutated LBS samples in all 16 major cancer types |
| Differential co-expressed gene network based on protein-protein interaction data (CePIN) |
| Top |
| Top |
| Phenotype information for SUN2 |
| Gene level disease information (DisGeNet) |
| Disease ID | Disease name | # PubMed | Association type |
| Mutation level pathogenic information (ClinVar annotation) |
| Allele ID | AA change | Clinical significance | Origin | Phenotype IDs |
| Top |
| Pharmacological information for SUN2 |
| Gene expression profile of anticancer drug treated cell-lines (CCLE) Heatmap showing the correlation between gene expression and drug response across all the cell-lines. We chose the top 20 among 138 drugs.We used Pearson's correlation coefficient. |
 |
| Drug information targeting mutLBSgene (Approved drugs only) |
| Drug status | DrugBank ID | Name | Type | Drug structure |
| Gene-centered ligand-gene interaction network |
 |
| Ligands binding to mutated ligand binding site of SUN2 go to BioLip |
| Ligand ID | Ligand short name | Ligand long name | PDB ID | PDB name | mutLBS | III | Peptide ligand (SER,CYS,ALA,LEU,SER,ASN,ASN,PHE,ALA,ARG,SER,PHE,HIS,PRO,MET,LEU,ARG,TYR,THR,ASN,GLY,PRO,PRO,PRO,LEU) | 4dxr | A | C601 A603 Y703 Y707 | III | Peptide ligand (CYS,THR,GLN,ALA,ASN,ASN,PHE,ALA,ARG,SER,PHE,TYR,PRO,MET,LEU,ARG,TYR,THR,ASN,GLY,PRO,PRO,PRO,THR) | 4dxs | A | C601 A603 Y703 Y707 | III | Peptide ligand (PHE,TYR,PRO,MET,LEU,ARG,TYR,THR,ASN,GLY,PRO,PRO,PRO,THR) | 4fi9 | A | C601 A603 Y703 Y707 |
| Top |
| Conservation information for LBS of SUN2 |
| Multiple alignments for Q9UH99 in multiple species |
| LBS | AA sequence | # species | Species |
 |
Copyright © 2016-Present - The University of Texas Health Science Center at Houston |